BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6145768)

  • 1. Evidence that a novel dopamine receptor agonist, RDS-127 [2-di-n-propylamino-4,7-dimethoxyindane] has some centrally mediated cardiovascular actions.
    Arnerić SP; Long JP
    J Pharm Pharmacol; 1984 May; 36(5):318-21. PubMed ID: 6145768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent anorexic-like effects of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in the rat: a comparison with other dopamine-receptor agonists.
    Arnerić SP; Roetker A; Long JP
    Neuropharmacology; 1982 Sep; 21(9):885-90. PubMed ID: 6897285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
    Arnerić SP; Chow SA; Long JP; Fischer LJ
    J Pharmacol Exp Ther; 1984 Mar; 228(3):551-9. PubMed ID: 6142939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of centrally mediated cardiovascular actions of the three structurally different calcium antagonists, verapamil, diltiazem and nicardipine, in rats.
    Imai Y; Abe K; Sasaki S; Minami N; Seino M; Yoshinaga K; Taira N
    Tohoku J Exp Med; 1987 Jan; 151(1):65-80. PubMed ID: 3576611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular effects of intracerebroventricular injection of dopamine after selective MAO inhibition in rats.
    Pazos A; Mediavilla A; Flórez J
    Neuropharmacology; 1982 Apr; 21(4):317-22. PubMed ID: 6283412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of pimozide and metergoline to antagonize the RDS-127-induced facilitation of ejaculatory behavior.
    Clark JT; Smith ER
    Physiol Behav; 1986; 37(1):47-52. PubMed ID: 3737722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiovascular effects of centrally administered 5-hydroxytryptamine in the conscious normotensive and hypertensive rat.
    Dalton DW
    J Auton Pharmacol; 1986 Mar; 6(1):67-75. PubMed ID: 3957952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central effects of RDS-127: sexual behavior after intracerebroventricular administration and in vitro receptor binding studies.
    Clark JT; Peroutka SJ; Ciaranello RD; Smith ER; Davidson JM
    Behav Brain Res; 1985 Dec; 18(3):251-60. PubMed ID: 2936365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antimuscarinic activity of a dopamine receptor agonist (RDS-127) differentiates M2-muscarinic receptors of heart, ileum and trachea in guinea-pig.
    Sahin I; Ilhan M
    Arch Int Pharmacodyn Ther; 1988; 296():163-72. PubMed ID: 2907277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of alpha-adrenoceptor agonistic activity of RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane) in rabbit and rat aortae.
    Rezaki YE; Ilhan M
    Arch Int Pharmacodyn Ther; 1991; 310():76-86. PubMed ID: 1685313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of the central cholinergic system in the pressor and bradycardic effects of centrally administrated melittin in normotensive conscious rats.
    Yalcin M; Erturk M
    Neuropeptides; 2007 Apr; 41(2):103-10. PubMed ID: 17222905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a novel dopamine-receptor agonist RDS-127 (2-N,N-di-n-propylamino-4,7-dimethoxyindane), on hormone levels and sexual behavior in the male rat.
    Clark JT; Smith ER; Stefanick ML; Arnerić SP; Long JP; Davidson JM
    Physiol Behav; 1982 Jul; 29(1):1-6. PubMed ID: 7122715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on alterations in male rat copulatory behavior induced by the dopamine-receptor agonist RDS-127.
    Clark JT; Stefanick ML; Smith ER; Davidson JM
    Pharmacol Biochem Behav; 1983 Nov; 19(5):781-6. PubMed ID: 6647512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of cholinergic mechanisms in the central cardiovascular actions of nicardipine in dogs.
    Montastruc JL; Dang Tran L; Huchet-Brisac AM; Chelly J; Rostin M; Montastruc P
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):212-6. PubMed ID: 3426347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors.
    Brown MJ; Harland D
    Br J Pharmacol; 1986 Feb; 87(2):361-70. PubMed ID: 3006858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic dopamine receptor stimulation in the cardiovascular actions of lergotrile.
    Barrett RJ; Lokhandwala MF
    J Pharmacol Exp Ther; 1981 Jun; 217(3):660-5. PubMed ID: 6112262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central muscarinic involvement in cardiovascular control in sinoaortic-denervated rats.
    Taira CA; Enero MA
    Eur J Pharmacol; 1989 Jan; 159(3):265-72. PubMed ID: 2920776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist.
    Gradin K; Pettersson A; Hjorth S; Hedner T; Arvidsson LE; Persson B
    J Pharm Pharmacol; 1985 Apr; 37(4):263-5. PubMed ID: 2860226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of semirigid methoxamine analogs on vascular smooth muscle: studies of methoxy-2-aminotetralin and 2-aminoindane derivatives.
    Arnerić SP; Roetker A; Long JP; Mott J; Barfknecht CF
    Arch Int Pharmacodyn Ther; 1982 Jun; 257(2):263-73. PubMed ID: 7114973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.